We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Bacterial Biofilms Associated with Colon Cancer

By LabMedica International staff writers
Posted on 21 Dec 2014
An imaging technology reveals that bacterial biofilms are associated with colon cancer (CRC) and the discovery draws on a novel way to observe microbial community structure.

The technology called combinatorial imaging could potentially be used to clinically diagnose pre-cancerous and cancerous conditions in the ascending colon, the part nearest to the small intestine. More...
Cancerous tumors in the ascending colon are characterized by biofilms, which are dense clumps of bacterial cells encased in a self-produced matrix.

Scientists at Johns Hopkins Medical Institutions (Baltimore, MD, USA) working with colleagues at the Marine Biological Laboratory, (Woods Hole, MA, USA) collected for analysis excess colon tumor, adenomas and cancers, and paired normal tissues from patients undergoing surgery. Healthy control patients undergoing screening colonoscopy or colonoscopy for diagnostic workup were also enrolled.

Colon tissues were analyzed with up to 11 fluorescent in situ hybridization (FISH) probes for bacterial composition and biofilm bacterial density and depth; by scanning electron microscopy (SEM), fluorescence microscopy for interleukin 6 (IL-6), and E-cadherin, enzyme-linked immunosorbent assay (ELISA) for (IL-6), and immunohistochemistry for pStat3, Ki67. Extracted sample DNA was amplified and sequence to determine the V3–V5 region of 16S rDNA using the Roche 454 method (Roche diagnostics; Branford, CT, USA).

The team identified invasive polymicrobial bacterial biofilms or bacterial aggregates structures previously associated with nonmalignant intestinal pathology. They were nearly universally on right-sided tumors (13 of 15 CRCs, 4 of 4 adenomas), but on only 12% of left-sided tumors (2 of 15 CRCs, 0 of 2 adenomas). Patients with biofilm-positive tumors, whether cancers or adenomas, all had biofilms on their tumor-free mucosa far distant from their tumors. Bacterial biofilms were associated with diminished colonic epithelial cell E-cadherin and enhanced epithelial cell IL-6 and Stat3 activation, as well as increased crypt epithelial cell proliferation in normal colon mucosa.

Jessica L. Mark Welch, PhD, a coauthor of the study, said, “This is the first time that biofilms have been shown to be associated with colon cancer, to our knowledge. This suggests that either the tumor allows the biofilm to form, or the biofilm is helping to cause the tumor. The breaching of the mucus layer could allow bacteria to come into contact with the host epithelial cells, and that is one thing that could lead to cancer.” The study was published on December 8, 2014, in the journal Proceedings of the National Academy of Sciences of the United States of America (PNAS).

Related Links:

Johns Hopkins Medical Institutions
Marine Biological Laboratory
Roche Diagnostics 




Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Serological Pipet Controller
PIPETBOY GENIUS
New
Silver Member
Quality Control Material
Multichem ID-B
New
Integrated Biochemical & Immunological System
Biolumi CX8
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: The discovery of early markers for ovarian cancer that would have improved sensitivity could aid detection (Photo courtesy of Adobe Stock)

Highly Accurate Biomarkers Could Detect Ovarian Cancer Before Clinical Diagnosis

Ovarian cancer is a deadly and challenging disease, primarily because early detection is difficult. Most women (70-75%) are diagnosed only after the cancer has already spread, which significantly reduces... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: CellLENS enables the potential precision therapy strategies against specific immune cell populations in the tissue environment (Photo courtesy of MIT)

New AI System Uncovers Hidden Cell Subtypes to Advance Cancer Immunotherapy

To produce effective targeted therapies for cancer, scientists need to isolate the genetic and phenotypic characteristics of cancer cells, both within and across different tumors. These differences significantly... Read more

Technology

view channel
Image: The Check4 gene-detection platform (Photo courtesy of IdentifySensors)

Electronic Biosensors Used to Detect Pathogens Can Rapidly Detect Cancer Cells

A major challenge in healthcare is the early and affordable detection of serious diseases such as cancer. Early diagnosis remains difficult due to the complexity of identifying specific genetic markers... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.